These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32662897)

  • 1. The importance of ultrasound preceding cell-free DNA screening for fetal chromosomal abnormalities.
    Brown I; Fernando S; Menezes M; da Silva Costa F; Ramkrishna J; Meagher S; Rolnik DL
    Prenat Diagn; 2020 Oct; 40(11):1439-1446. PubMed ID: 32662897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester screening based on cell-free DNA vs combined screening: A randomized clinical trial on women's experience.
    Migliorini S; Saccone G; Silvestro F; Massaro G; Arduino B; D'Alessandro P; Petti MT; Paino JAC; Guida M; Locci M; Zullo F
    Prenat Diagn; 2020 Oct; 40(11):1482-1488. PubMed ID: 32683755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When ultrasound anomalies are present: An estimation of the frequency of chromosome abnormalities not detected by cell-free DNA aneuploidy screens.
    Reimers RM; Mason-Suares H; Little SE; Bromley B; Reiff ES; Dobson LJ; Wilkins-Haug L
    Prenat Diagn; 2018 Mar; 38(4):250-257. PubMed ID: 29436713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fibroids on cell-free DNA screening accuracy.
    Scott F; Menezes M; Smet ME; Carey K; Hardy T; Fullston T; Rolnik DL; McLennan A
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):114-119. PubMed ID: 34396623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free fetal DNA testing in singleton IVF conceptions.
    Lee TJ; Rolnik DL; Menezes MA; McLennan AC; da Silva Costa F
    Hum Reprod; 2018 Apr; 33(4):572-578. PubMed ID: 29462319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of noninvasive prenatal screening with cell-free DNA in late pregnancy with sonographic soft markers.
    Wan JH; Zhen L; Han J; Pan M; Yang X; Li DZ
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():431-433. PubMed ID: 32721841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound findings and detection of fetal abnormalities before 11 weeks of gestation.
    Brown I; Rolnik DL; Fernando S; Menezes M; Ramkrishna J; da Silva Costa F; Meagher S
    Prenat Diagn; 2021 Dec; 41(13):1675-1684. PubMed ID: 34643279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy.
    Vora NL; Robinson S; Hardisty EE; Stamilio DM
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):465-469. PubMed ID: 27300317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women.
    Yao H; Gao Y; Zhao J; Zhang R; Xu H; Hu H; Luo Y; Yuan Y; Fu M; Zhang H; Jiang H; Wang W; Yang H; Wang J; Liang Z; Chen F
    Sci China Life Sci; 2019 Feb; 62(2):215-224. PubMed ID: 30076564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell-free fetal DNA analysis in maternal plasma as a screening test for trisomy 21 in twin pregnancies].
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):580-586. PubMed ID: 29929941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of chromosomal abnormalities in fetuses with first trimester ultrasound anomalies and a low-risk cell-free DNA test for common trisomies.
    Persico N; Boito S; Volpe P; Ischia B; Gentile M; Ronzoni L; De Robertis V; Fabietti I; Olivieri C; Periti E; Ficarella R; Silipigni R; Rembouskos G
    Prenat Diagn; 2020 Oct; 40(11):1474-1481. PubMed ID: 33034897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
    Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
    Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.
    Galeva S; Gil MM; Konstantinidou L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):804-809. PubMed ID: 30977206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
    Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
    Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.
    Malan V; Bussières L; Winer N; Jais JP; Baptiste A; Le Lorc'h M; Elie C; O'Gorman N; Fries N; Houfflin-Debarge V; Sentilhes L; Vekemans M; Ville Y; Salomon LJ;
    JAMA; 2018 Aug; 320(6):557-565. PubMed ID: 30120476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.